Bertram Bengsch

2PUBLICATIONS
31CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC.

Eva Stockinger, Hendrik Luxenburger, Dominik Bettinger

|Oct 27, 2023
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.

Vincent Joerg, Bernhard Scheiner, Antonio D Alessio

Pageof 1

Frequent Collaborators

1 joint publications

Bernhard Scheiner

1 joint publications

Antonio D Alessio

1 joint publications

Claudia A M Fulgenzi

1 joint publications

Martin Schönlein

1 joint publications

Lorenz Kocheise

1 joint publications

Ansgar W Lohse

1 joint publications

Samuel Huber

1 joint publications

Henning Wege

1 joint publications

Jaekyung Cheon

1 joint publications

Lorenz Balcar

Frequent Collaborators

1 joint publications

Bernhard Scheiner

1 joint publications

Antonio D Alessio

1 joint publications

Claudia A M Fulgenzi

1 joint publications

Martin Schönlein

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on : Jun 02, 2022

2.6K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
See more related videos

Top Related Videos

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on : Jun 02, 2022

2.6K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
See more related videos